Microscopic polyangiitis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 17: Line 17:


====Anti-neutrophil cytoplasmic antibodies (ANCA)====
====Anti-neutrophil cytoplasmic antibodies (ANCA)====
==Overview==
The [[pathogenesis]] of [[Microscopic polyangiitis]] is currently not fully understood. However, certain [[Hypothesis|hypothesizes]] have been made to determine possible factors that may trigger the disease such as environmental factors and [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies.]] [[Capillary|Capillaries]] and [[venules]] are involved in the [[pathogenesis]] of [[microscopic polyangiitis]].The paucity of [[immunoglobulin]] deposition is shown in [[Immunohistochemical staining|Immunohistochemical]] staining.
==Pathogenesis==
====Pathogenesis====
*The exact [[etiology]] of [[Microscopic polyangiitis]] is not fully understood.
*Certain [[Hypothesis|hypothesizes]] have been made to determine possible factors that may trigger the disease.
*Triggers such as [[Environmental factor|environmental factors]] and [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]].
=====Environmental triggers=====
*Environmental triggers such as exposure to [[silica]] have been found to influence the progression of the disease.But, its role in disease progression is not fully understood.<ref name="pmid180777832">{{cite journal| author=de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW et al.| title=Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. | journal=Clin J Am Soc Nephrol | year= 2008 | volume= 3 | issue= 1 | pages= 237-52 | pmid=18077783 | doi=10.2215/CJN.03550807 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18077783  }}</ref>
====Anti-neutrophil cytoplasmic antibodies (ANCA)<ref name="pmid15855209">{{cite journal |vauthors=Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, Lesavre P, Noël LH |title=ANCA-negative pauci-immune renal vasculitis: histology and outcome |journal=Nephrol. Dial. Transplant. |volume=20 |issue=7 |pages=1392–9 |date=July 2005 |pmid=15855209 |doi=10.1093/ndt/gfh830 |url=}}</ref>====
*The majority of patients who are affected with [[Microscopic polyangiitis]] are positive for [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]] ([[ANCA]]) with [[myeloperoxidase]] antigen activity.
*The presence of [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]] ([[ANCA]]) activates neutrophil production do to [[proinflammatory]] [[Cytokine|cytokines]] such as ''[[Interleukin 1|interleukin-1]]'' and ''[[Tumor necrosis factor-alpha|tumor necrosis factor-α]](TNF-ALPHA).''
*Stimulation of ''[[Interleukin 1|interleukin-1]]'' and ''tumor necrosis factor-α(TNF-ALPHA)'' results in producing [[reactive oxygen species]] and causing the release of [[lytic]] enzymes.
*These two processes, induce detachment and lyses of the [[endothelium]].
*The destruction of the [[Endothelial cells|endothelial]] cells results in [[necrotizing]] [[Crescentic glomerulonephritis|crescentic]] glomerulonephritis and [[Necrosis|necrotizing]] [[vasculitis]] of the pulmonary [[capillaries]].<ref name="pmid171332512">{{cite journal| author=Kallenberg CG, Heeringa P, Stegeman CA| title=Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. | journal=Nat Clin Pract Rheumatol | year= 2006 | volume= 2 | issue= 12 | pages= 661-70 | pmid=17133251 | doi=10.1038/ncprheum0355 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17133251  }}</ref>
==Genetics==
*[[Microscopic polyangiitis]] is correlated with [[HLA-DRB1]]*09:01-DQB1*03:03 [[haplotype]] in the Japanese population. This [[haplotype]] however, in the Caucasian population is not typically seen.<ref name="pmid235555272">{{cite journal| author=Tsuchiya N| title=Genetics of microscopic polyangiitis in the Japanese population. | journal=Ann Vasc Dis | year= 2012 | volume= 5 | issue= 3 | pages= 289-95 | pmid=23555527 | doi=10.3400/avd.ra.12.00062 | pmc=3595849 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23555527  }}</ref>
==Gross Pathology==
*On gross pathology, the following changes are typically seen:<ref name="pmid193272492">{{cite journal| author=Gómez-Puerta JA, Espinosa G, Morlà R, Cid MC, Cervera R| title=Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil. | journal=Clin Exp Rheumatol | year= 2009 | volume= 27 | issue= 1 | pages= 166-7 | pmid=19327249 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19327249  }}</ref><ref name="pmid206882493">{{cite journal| author=Chung SA, Seo P| title=Microscopic polyangiitis. | journal=Rheum Dis Clin North Am | year= 2010 | volume= 36 | issue= 3 | pages= 545-58 | pmid=20688249 | doi=10.1016/j.rdc.2010.04.003 | pmc=2917831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20688249  }}</ref>
**[[Hemorrhagic]] [[necrotizing]] [[alveolar]] capillaritis.
**[[Fibrinoid necrosis|Fibrinoid]] necrosis of the lung.
**Intra-alveolar [[hemosiderosis]].
==Microscopic Pathology==
*On [[microscopic]] histopathological analysis of the [[Renal|kidney]]<ref name="pmid40483892">{{cite journal| author=Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM| title=Microscopic polyarteritis: presentation, pathology and prognosis. | journal=Q J Med | year= 1985 | volume= 56 | issue= 220 | pages= 467-83 | pmid=4048389 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4048389  }}</ref><ref name="pmid2068824922">{{cite journal| author=Chung SA, Seo P| title=Microscopic polyangiitis. | journal=Rheum Dis Clin North Am | year= 2010 | volume= 36 | issue= 3 | pages= 545-58 | pmid=20688249 | doi=10.1016/j.rdc.2010.04.003 | pmc=2917831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20688249  }}</ref>
**Focal [[Segmental analysis (biology)|segmental]] necrotizing [[glomerulonephritis]].
**Crescents of [[glomeruli]].
**Minimal deposition of [[immunoglobulins]].
**Compliment in [[glomeruli]] and renal [[vasculature]] can be seen.
* The majority of patients who are affected with [[Microscopic polyangiitis]] are positive for [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]] ([[ANCA]]) with [[myeloperoxidase]] antigen activity.  
* The majority of patients who are affected with [[Microscopic polyangiitis]] are positive for [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]] ([[ANCA]]) with [[myeloperoxidase]] antigen activity.  
* The presence of [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]] ([[ANCA]]) activates neutrophil production do to [[proinflammatory]] [[Cytokine|cytokines]] such as ''[[Interleukin 1|interleukin-1]]'' and ''[[Tumor necrosis factor-alpha|tumor necrosis factor-α]](TNF-ALPHA).''
* The presence of [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]] ([[ANCA]]) activates neutrophil production do to [[proinflammatory]] [[Cytokine|cytokines]] such as ''[[Interleukin 1|interleukin-1]]'' and ''[[Tumor necrosis factor-alpha|tumor necrosis factor-α]](TNF-ALPHA).''

Revision as of 19:38, 18 April 2018

Microscopic polyangiitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microscopic polyangiitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microscopic polyangiitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microscopic polyangiitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microscopic polyangiitis pathophysiology

CDC on Microscopic polyangiitis pathophysiology

Microscopic polyangiitis pathophysiology in the news

Blogs on Microscopic polyangiitis pathophysiology

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Microscopic polyangiitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]Vamsikrishna Gunnam M.B.B.S [4]

Overview

The pathogenesis of Microscopic polyangiitis is currently not fully understood. However, certain hypothesizes have been made to determine possible factors that may trigger the disease such as environmental factors and anti-neutrophil cytoplasmic antibodies. Capillaries and venules are involved in the pathogenesis of microscopic polyangiitis.The paucity of immunoglobulin deposition is shown in Immunohistochemical staining.

Pathogenesis

Pathogenesis

Environmental triggers
  • Environmental triggers such as exposure to silica have been found to influence the progression of the disease.But, its role in disease progression is not fully understood.[1]

Anti-neutrophil cytoplasmic antibodies (ANCA)

Overview

The pathogenesis of Microscopic polyangiitis is currently not fully understood. However, certain hypothesizes have been made to determine possible factors that may trigger the disease such as environmental factors and anti-neutrophil cytoplasmic antibodies. Capillaries and venules are involved in the pathogenesis of microscopic polyangiitis.The paucity of immunoglobulin deposition is shown in Immunohistochemical staining.

Pathogenesis

Pathogenesis

Environmental triggers
  • Environmental triggers such as exposure to silica have been found to influence the progression of the disease.But, its role in disease progression is not fully understood.[2]

Anti-neutrophil cytoplasmic antibodies (ANCA)[3]

Genetics

Gross Pathology

Microscopic Pathology

Genetics

Gross Pathology

Microscopic Pathology

References

  1. de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW; et al. (2008). "Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known". Clin J Am Soc Nephrol. 3 (1): 237–52. doi:10.2215/CJN.03550807. PMID 18077783.
  2. de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW; et al. (2008). "Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known". Clin J Am Soc Nephrol. 3 (1): 237–52. doi:10.2215/CJN.03550807. PMID 18077783.
  3. Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, Lesavre P, Noël LH (July 2005). "ANCA-negative pauci-immune renal vasculitis: histology and outcome". Nephrol. Dial. Transplant. 20 (7): 1392–9. doi:10.1093/ndt/gfh830. PMID 15855209.
  4. Kallenberg CG, Heeringa P, Stegeman CA (2006). "Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides". Nat Clin Pract Rheumatol. 2 (12): 661–70. doi:10.1038/ncprheum0355. PMID 17133251.
  5. Tsuchiya N (2012). "Genetics of microscopic polyangiitis in the Japanese population". Ann Vasc Dis. 5 (3): 289–95. doi:10.3400/avd.ra.12.00062. PMC 3595849. PMID 23555527.
  6. Gómez-Puerta JA, Espinosa G, Morlà R, Cid MC, Cervera R (2009). "Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil". Clin Exp Rheumatol. 27 (1): 166–7. PMID 19327249.
  7. Chung SA, Seo P (2010). "Microscopic polyangiitis". Rheum Dis Clin North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
  8. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985). "Microscopic polyarteritis: presentation, pathology and prognosis". Q J Med. 56 (220): 467–83. PMID 4048389.
  9. Chung SA, Seo P (2010). "Microscopic polyangiitis". Rheum Dis Clin North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
  10. Kallenberg CG, Heeringa P, Stegeman CA (2006). "Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides". Nat Clin Pract Rheumatol. 2 (12): 661–70. doi:10.1038/ncprheum0355. PMID 17133251.
  11. Tsuchiya N (2012). "Genetics of microscopic polyangiitis in the Japanese population". Ann Vasc Dis. 5 (3): 289–95. doi:10.3400/avd.ra.12.00062. PMC 3595849. PMID 23555527.
  12. Gómez-Puerta JA, Espinosa G, Morlà R, Cid MC, Cervera R (2009). "Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil". Clin Exp Rheumatol. 27 (1): 166–7. PMID 19327249.
  13. Chung SA, Seo P (2010). "Microscopic polyangiitis". Rheum Dis Clin North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
  14. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985). "Microscopic polyarteritis: presentation, pathology and prognosis". Q J Med. 56 (220): 467–83. PMID 4048389.
  15. Chung SA, Seo P (2010). "Microscopic polyangiitis". Rheum Dis Clin North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.

Template:WH Template:WS